Status:

TERMINATED

Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

Hyper-IgM Syndrome

Ectodermal Dysplasia

Eligibility:

All Genders

Brief Summary

This study investigates gene abnormalities in Primary Immune Deficiency(PID) with a goal of improving the diagnosis and treatment of patients. The specific disorders include: 1. X linked hyper IgM S...

Detailed Description

This protocol is designed to study the genetics and pathophysiology of Hyper-IgM syndrome, NEMO associated immune deficiency, patients with related primary immune deficiency disorders, and the blood r...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • All patients must have a known or suspected immune defect with hyper-IgM syndrome and/or disorders of immunoglobulin production. There will be no limit on age, sex, race, or disability. Normal volunteers must be healthy adults between the age of 18 and 70 years. All study participants enrolled on to this study must agree to allow PI to store research samples. Refusal to let PI store samples may lead to withdrawal fro this specific study.
  • EXCLUSION CRITERIA:
  • The presence of an acquired abnormality, which leads to immune defects, such as HIV, chemotherapy, and malignancy are general exclusion criteria. Refusal to let us store samples may lead to withdrawal from this specific study. Other factors, which are in the judgment of the Principal Investigator PI that may interfere with patient evaluation or determine to pose an added risk for study participants are also criteria for exclusion.

Exclusion

    Key Trial Info

    Start Date :

    December 14 2005

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    July 11 2013

    Estimated Enrollment :

    119 Patients enrolled

    Trial Details

    Trial ID

    NCT00266513

    Start Date

    December 14 2005

    End Date

    July 11 2013

    Last Update

    October 6 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Bethesda, Maryland, United States, 20892